Merck and NanoString Technologies, Inc. today announced a clinical research collaboration to develop an assay that will optimize immune-related gene expression signatures.
BUSINESS WIRE
Advertisement
Articles by BUSINESS WIRE
Multiple Sclerosis patient Jack Osbourne unveils new resources to empower others with Multiple Sclerosis to take a more active role in managing disease.
Advertisement
Latest Updated Articles
- Jack Osbourne and Teva Launch Enhanced You Don't Know Jack About MS® Website Featuring New Multimedia Content
Published: May 27th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1 Receptor Agonists Show Promise Across Alcohol, Opioid, and Tobacco Use Disorders
2
TACTI-004 Trial Studying Eftilagimod Alfa With Pembrolizumab in Advanced NSCLC to Begin Evaluation
3
UConn’s Medical Writing Certificate Program: It’s Just "Write"
4
Pharmacy Policy Updates for October 2025
5
